tiprankstipranks
Ocean Biomedical Faces Nasdaq Non-Compliance Notice and Delays
Company Announcements

Ocean Biomedical Faces Nasdaq Non-Compliance Notice and Delays

Don't Miss our Black Friday Offers:

An update from Ocean Biomedical (OCEA) is now available.

Ocean Biomedical, Inc. has delayed its quarterly report filing, leading to a notice from Nasdaq for non-compliance with its listing rules. The company is required to submit a compliance plan by June 14, 2024, and file the overdue report by October 14, 2024. This delay currently does not affect its stock trading status, but there’s no guarantee that continued delays won’t impact it in the future. Ocean Biomedical aims to file the pending report promptly.

See more insights into OCEA stock on TipRanks’ Stock Analysis page.

Related Articles
TheFlyOcean Biomedical receives noncompliance letter from Nasdaq
TheFlyOcean Biomedical, Molecure sign licensing agreement for YKL-40 inhibitors
TheFlyOcean Biomedical’s oncology platform included in new published study
Looking for investment ideas? Subscribe to our Smart Investor newsletter for weekly expert stock picks!
Get real-time notifications on news & analysis, curated for your stock watchlist. Download the TipRanks app today! Get the App